Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
local progression
Description:
The growth or worsening of disease at its original site, particularly tumor progression during or after cancer treatment.
Related topics:
Lung Cancer Diagnosis and Treatment (11%),
Prostate Cancer Diagnosis and Treatment (11%),
Brain Metastases and Treatment (10%)
OpenAlex ID:
keywords/local-progression
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
2002
·
Lars Holmberg
, Anna Bill-Axelson
, et al.
·
New England Journal of Medicine
·
881
PDF
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial
1997
·
Reza Adib
, John Anderson
, et al.
·
British Journal of Urology
·
753
Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
2008
·
Eric M. Horwitz
, Kyounghwa Bae
, et al.
·
Journal of Clinical Oncology
·
717
PDF
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
1992
·
R Umbas
, J A Schalken
, et al.
·
PubMed
·
675
Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
2013
·
Ilya Laufer
, J. Bryan Iorgulescu
, et al.
·
Journal of Neurosurgery Spine
·
537
PDF
Excise, Ablate or Observe: The Small Renal Mass Dilemma—A Meta-Analysis and Review
2008
·
David A. Kunkle
, Brian L. Egleston
, et al.
·
The Journal of Urology
·
531
Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer
2011
·
Michael A.S. Jewett
, Kamal Mattar
, et al.
·
European Urology
·
525
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
2011
·
James W Denham
, Allison Steigler
, et al.
·
The Lancet Oncology
·
481
Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience
1998
·
Minoru Uematsu
, Akira Shioda
, et al.
·
Cancer
·
318
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
2019
·
Christian Carrie
, Nicolas Magné
, et al.
·
The Lancet Oncology
·
272
PDF
Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up
2012
·
Marcin Popiolek
, Jennifer R. Rider
, et al.
·
European Urology
·
264
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial
2014
·
Peter J Hoskin
, Amy A Kirkwood
, et al.
·
The Lancet Oncology
·
261
The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery
2017
·
Yoshiya Yamada
, Evangelia Katsoulakis
, et al.
·
Neurosurgical FOCUS
·
227
PDF
Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer
2007
·
James D. Murphy
, Saroja Adusumilli
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
222
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
2002
·
Christopher H Crane
, James L Abbruzzese
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
210
Expectant management of localized prostatic cancer
1991
·
Willet F. Whitmore
, John A. Warner
, et al.
·
Cancer
·
202
High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent Lymphomas
2003
·
R.L.M. Haas
, Ph. Poortmans
, et al.
·
Journal of Clinical Oncology
·
187
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer
1990
·
Howard M. Sandler
, Walter J. Curran
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
183
Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer
2014
·
Nami Ueki
, Yukinori Matsuo
, et al.
·
Journal of Thoracic Oncology
·
182
Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma
2017
·
Daniel von Allmen
, Andrew M. Davidoff
, et al.
·
Journal of Clinical Oncology
·
178
Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma
2010
·
Michael T. Milano
, Paul Okunieff
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
176
Chondrosarcoma of the spine.
1989
·
T C Shives
, R A McLeod
, et al.
·
Journal of Bone and Joint Surgery
·
172
Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer
2012
·
Jin-Ji Yang
, Hua-Jun Chen
, et al.
·
Lung Cancer
·
170
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
2009
·
Kyle E. Rusthoven
, Susan F. Hammerman
, et al.
·
Acta Oncologica
·
169
PDF
Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases: a multicentre randomized Phase II study
1999
·
D. Liénard
, A. M. M. Eggermont
, et al.
·
Melanoma Research
·
162
Show more works
View as search
Works count:
897
Citation count:
20,200
Year
Topic
Type